Header cover image

U.S. Large Cap High Growth Potential

UPDATED May 21, 2022

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

219 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
CRWDCrowdStrike HoldingsUS$148.74-4.8%-29.4%US$34.5bUS$256.20PS23.8xE47.5%n/aSoftware
OWLBlue Owl CapitalUS$11.684.9%0.7%US$16.3bUS$16.05PS16.5xE121.2%3.4%Diversified Financials
NUNu HoldingsUS$3.81-21.0%n/aUS$17.8bUS$8.71PB3.7xE75.1%n/aBanks
ENPHEnphase EnergyUS$168.256.6%18.3%US$22.7bUS$222.46PS137.2xE36.2%n/aSemiconductors
DDOGDatadogUS$94.79-12.9%6.6%US$29.9bUS$169.58PS14493.9xE81.2%n/aSoftware
TTDTrade DeskUS$52.641.4%-2.5%US$25.6bUS$72.27PS254.7xE48.9%n/aSoftware
LVSLas Vegas SandsUS$33.46-3.5%-42.0%US$25.6bUS$48.00PS6.4xE34.6%0%Consumer Services
MELIMercadoLibreUS$775.65-2.4%-43.3%US$39.1bUS$1,528.09PS214.3xE37.0%0%Retail
TSLATeslaUS$663.90-13.7%14.3%US$687.8bUS$963.33PS81.8xE24.0%n/aAutomobiles
PANWPalo Alto NetworksUS$478.68-2.5%32.1%US$47.1bUS$630.39PS9.1xE53.0%n/aSoftware
BHVNBiohaven Pharmaceutical HoldingUS$142.030.7%79.4%US$10.1bUS$160.75PS13.7xE70.7%n/aPharmaceuticals & Biotech
ALNYAlnylam PharmaceuticalsUS$132.274.6%-5.6%US$16.0bUS$204.23PS18.2xE74.4%n/aPharmaceuticals & Biotech
ALGNAlign TechnologyUS$275.04-0.2%-53.5%US$21.7bUS$444.67PS30.7xE21.9%n/aHealthcare
EPAMEPAM SystemsUS$320.390.4%-32.9%US$18.3bUS$416.77PS39.6xE29.9%n/aSoftware
BSYBentley SystemsUS$32.812.2%-38.3%US$10.2bUS$48.25PS110.5xE23.2%0.4%Software
CHWYChewyUS$24.47-12.5%-63.9%US$10.3bUS$56.61PS1.2xE46.5%n/aRetail
PDDPinduoduoUS$40.908.4%-68.4%US$51.7bUS$66.46PS44.6xE29.6%n/aRetail
MRVLMarvell TechnologyUS$54.07-6.1%17.0%US$46.0bUS$92.79PS10.3xE73.2%0.4%Semiconductors
SBNYSignature BankUS$190.89-5.1%-20.5%US$11.9bUS$369.76PB1.5xE20.3%1.2%Banks
SNAPSnapUS$23.26-6.0%-58.9%US$38.1bUS$47.58PS8.6xE74.6%n/aMedia
PAYCPaycom SoftwareUS$276.79-4.1%-16.2%US$16.1bUS$381.34PS72xE25.1%n/aSoftware
FTNTFortinetUS$285.281.3%35.3%US$45.7bUS$361.63PS71.7xE20.4%n/aSoftware
ARESAres ManagementUS$66.76-2.6%21.4%US$19.6bUS$91.36PS54.3xE28.1%3.7%Diversified Financials
SLBSchlumbergerUS$41.120.9%28.7%US$58.1bUS$49.91PS27.8xE23.5%1.7%Energy
Page 1 of 10